Basis: Unrounded diluted TTM EPS / FMP quote price × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The earnings yield is N/A as of 2026-10-06T21:08:13.522Z.
Calculation as of: 2026-10-06T21:08:13.522Z.
Quote observation: 2026-10-06T20:00:00.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 833b8a33f5e3aa548e06775940c7a83493d9a3083fc648ecb3f8ecd80d633b38
EARNINGS YIELD
N/A
Market Cap
$241.94M
Earnings Yield
N/A
TTM Avg
2.23%
3Y Avg
2.23%
5Y Avg
2.23%
Market Cap
$235.97M
Earnings Yield
N/A
TTM Avg
11.64%
3Y Avg
12.85%
5Y Avg
11.39%
| NAME | MARKET CAP | EARNINGS YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Quantum-Si incorporated (QSI) | $241.34M | N/A | N/A | N/A | N/A |
| Q32 Bio Inc. (QTTB)vs › | $241.39M | 34.40% | 26.39% | 26.39% | 30.90% |
| Lifecore Biomedical, Inc. (LFCR)vs › | $241.94M | N/A | 2.23% | 2.23% | 2.23% |
| Century Therapeutics, Inc. (IPSC)vs › | $239.02M | N/A | N/A | N/A | N/A |
| High Tide Inc. (HITI)vs › | $239.01M | N/A | N/A | N/A | N/A |
| Invivyd, Inc. (IVVD)vs › | $237.57M | N/A | N/A | N/A | N/A |
| BioAge Labs Inc. (BIOA)vs › | $236.82M | N/A | N/A | N/A | N/A |
| SIGA Technologies, Inc. (SIGA)vs › | $235.97M | N/A | 11.64% | 12.85% | 11.39% |
| Akebia Therapeutics, Inc. (AKBA)vs › | $235.66M | N/A | N/A | N/A | N/A |
| Sol-Gel Technologies Ltd. (SLGL)vs › | $247.27M | N/A | 3.91% | 3.79% | 2.20% |
Earnings Yield
N/A
EPS ÷ Price
P/E Ratio
N/A
Price ÷ EPS
Formula: Earnings Yield = (EPS / Price) × 100
Earnings Yield is simply the inverse of P/E. A P/E of 20 equals a 5% earnings yield.
How earnings yield is used:
Earnings Yield = EPS (TTM) / Share Price
Earnings yield is the inverse of the PE ratio, expressing trailing earnings as a percentage of price. Higher is cheaper.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
